These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 14587263

  • 1. [Long-term effect of clopidogrel do exist--but hardly worth the costs].
    Hansen O.
    Lakartidningen; 2003 Oct 09; 100(41):3216-7. PubMed ID: 14587263
    [No Abstract] [Full Text] [Related]

  • 2. [ASA or clopidogrel?].
    Janzon L.
    Lakartidningen; 2000 May 31; 97(22):2775-6. PubMed ID: 10900900
    [No Abstract] [Full Text] [Related]

  • 3. [After coronary intervention. Which platelet inhibitor for whom?].
    Stiefelhagen P.
    MMW Fortschr Med; 2007 Apr 05; 149(14):18-9. PubMed ID: 17668756
    [No Abstract] [Full Text] [Related]

  • 4. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P, Stenestrand U, Malmberg K, Jönsson B.
    Clin Ther; 2005 Jan 05; 27(1):100-10. PubMed ID: 15763611
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial.
    Lindgren P, Jönsson B, Yusuf S.
    J Intern Med; 2004 May 05; 255(5):562-70. PubMed ID: 15078498
    [Abstract] [Full Text] [Related]

  • 8. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
    Weintraub WS, Mahoney EM, Lamy A, Culler S, Yuan Y, Caro J, Gabriel S, Yusuf S, CURE Study Investigators.
    J Am Coll Cardiol; 2005 Mar 15; 45(6):838-45. PubMed ID: 15766816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention.
    Cowper PA, Udayakumar K, Sketch MH, Peterson ED.
    J Am Coll Cardiol; 2005 Feb 01; 45(3):369-76. PubMed ID: 15680714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
    Walker CW, Dawley CA, Fletcher SF.
    Am Fam Physician; 2007 Dec 01; 76(11):1643-5. PubMed ID: 18092705
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The challenge of monitoring platelet response after clopidogrel.
    Serebruany VL, Goto S.
    Eur Heart J; 2008 Dec 01; 29(23):2833-4. PubMed ID: 18977768
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clopidogrel plus proton pump inhibitor: is infarct risk increased? (interview by Dr. Thomas Meissner)].
    Petersen KU.
    MMW Fortschr Med; 2009 Jun 04; 151(23):7. PubMed ID: 19591342
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.